4.6 Article

Efficacy and prognostic factors of repeated hepatectomy for postoperative intrahepatic recurrence of hepatocellular carcinoma undergoing initial hepatectomy

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Hepatocellular Carcinoma New Developments

Previn Ganesan et al.

CLINICS IN LIVER DISEASE (2023)

Review Gastroenterology & Hepatology

BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update

Maria Reig et al.

Summary: There have been significant advances in the treatment strategies for hepatocellular carcinoma since the last update in 2018. However, some interventions still lack sufficient data for clinical incorporation, and personalized clinical management requires consideration of multiple parameters.

JOURNAL OF HEPATOLOGY (2022)

Review Gastroenterology & Hepatology

Epidemiology of Hepatocellular Carcinoma

Katherine A. McGlynn et al.

Summary: Liver cancer, particularly hepatocellular carcinoma (HCC), is a major global health concern. While HBV and HCV remain important risk factors for HCC, efforts in vaccination and treatment are showing promise. However, the increasing prevalence of metabolic risk factors like obesity and diabetes, as well as other factors like excessive alcohol consumption, present ongoing challenges in the prevention of liver cancer.

HEPATOLOGY (2021)

Review Surgery

Liver Resection Versus Local Ablation Therapies for Hepatocellular Carcinoma Within the Milan Criteria A Systematic Review and Meta-analysis

Seong Wook Shin et al.

Summary: This study found that liver resection (LR) is more effective than local ablation therapies (such as RFA, MWA, and RFA plus TACE) in treating HCC within the Milan criteria. Specifically, LR has better 5-year recurrence-free survival and lower local recurrence rates compared to local ablation therapies.

ANNALS OF SURGERY (2021)

Review Gastroenterology & Hepatology

Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma

Josep M. Llovet et al.

Summary: Locoregional therapies, including local ablation and transarterial chemoembolization, play a crucial role in the management of hepatocellular carcinoma. Recent studies have shown potential benefits of combining these local therapies with systemic treatments, such as molecular therapies, to enhance therapeutic effects.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)

Article Surgery

Laparoscopic repeat liver resection for recurrent hepatocellular carcinoma

Brian K. P. Goh et al.

ANZ JOURNAL OF SURGERY (2017)

Review Oncology

Strategic overview on the best treatment option for intrahepaitc hepatocellular carcinoma recurrence

Wing Chiu Dai et al.

EXPERT REVIEW OF ANTICANCER THERAPY (2016)

Editorial Material Gastroenterology & Hepatology

Management of Hepatocellular Carcinoma: An Update

Jordi Bruix et al.

HEPATOLOGY (2011)

Review Medicine, General & Internal

CURRENT CONCEPTS Hepatocellular Carcinoma

Hashem B. El-Serag

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Article Surgery

Laparoscopic Repeat Resection of Recurrent Hepatocellular Carcinoma

Minggen Hu et al.

WORLD JOURNAL OF SURGERY (2011)

Editorial Material Oncology

The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM

Stephen B. Edge et al.

ANNALS OF SURGICAL ONCOLOGY (2010)

Article Gastroenterology & Hepatology

Treatment strategy for hepatocellular carcinoma: expanding the indications for radiofrequency ablation

Ryosuke Tateishi et al.

JOURNAL OF GASTROENTEROLOGY (2009)

Article Surgery

Repeat hepatectomy for recurrent hepatocellular carcinoma

Toshiyuki Itamoto et al.

SURGERY (2007)

Article Gastroenterology & Hepatology

Salvage living donor liver transplantation after prior liver resection for hepatocellular carcinoma

Shin Hwang et al.

LIVER TRANSPLANTATION (2007)

Review Oncology

A decade's studies on metastasis of hepatocellular carcinoma

ZY Tang et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2004)